The Acute Effects of Coffee on Glucose Metabolism

This study has been completed.

Sponsor:

Information provided by:

Brooklyn College of the City University of New York

ClinicalTrials.gov Identifier:

NCT00950898

First received: July 31, 2009

Last updated: NA

Last verified: July 2009

History: No changes posted

Tracking Information

First Received Date ^ICMJE

July 31, 2009

Last Updated Date

July 31, 2009

Start Date ^ICMJE

November 2006

Primary Completion Date

June 2007 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

plasma glucose levels [ Time Frame: 0, 10, 30, 60, 90, and 120 minutes. ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

plasma insulin [ Time Frame: 0, 10, 30, 60, 90, and 120 minutes ] [ Designated as safety issue: No ]

Original Secondary Outcome Measures ^ICMJE

Same as current

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

The Acute Effects of Coffee on Glucose Metabolism

Official Title ^ICMJE

Human Trial of the Acute Effects of Coffee on Glucose Metabolism

Brief Summary

The purpose of this study was to determine the acute effects of decaffeinated coffee, caffeinated coffee and caffeine on glucose metabolism in humans

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Not Provided

Study Design ^ICMJE

Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science

Condition ^ICMJE

Type 2 Diabetes

Intervention ^ICMJE

Other: decaff
2 mugs of decaffeinated coffee
Other: caffcoff
2 mugs of caffeinated coffee
Other: caffeine
2 mugs of hot water containing caffeine
Other: placebo
2 mugs of hot water

Study Arm (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

June 2007

Primary Completion Date

June 2007 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

healthy young males
nonsmokers
moderate alcohol users

Exclusion Criteria:

not on any medications that could alter glucose metabolism
no history of blood disorders

Gender

Male

Ages

18 Years to 35 Years

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT Number ^ICMJE

NCT00950898

Other Study ID Numbers ^ICMJE

07-020

Has Data Monitoring Committee

Responsible Party

James Greenberg, PhD., Principal Investigator, Brooklyn College of the City University of New York

Study Sponsor ^ICMJE

Brooklyn College of the City University of New York

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

James Greenberg, Ph.D.

Brooklyn College of the City University of New York

Information Provided By

Brooklyn College of the City University of New York

Verification Date

July 2009

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top